[#item_full_content] [[{“value”:”The market shaved about 2.8% off Trulieve Cannabis stock today, yet the headline from this quarter is not a demand problem. The story is the hit to reported earnings from the Harvest deconsolidation and the way it distorts the income statement.
Trulieve posted a reported net loss of about US$406 million for Q2 on revenue of US$271 million. However, management pointed to roughly US$20 million of underlying net income once the one time Harvest impact is stripped out. For a medical cannabis…”}]] Read More
